IP Library › Assignment 043341/0481
Patent Assignment
Reel/Frame 043341/0481

Change of Name

Recorded: 2017-07-26 Pages: 4
Assignor
ISIS PHARMACEUTICALS, INC.
Executed: 2015-12-18
Assignee
IONIS PHARMACEUTICALS, INC.
2855 GAZELLE COURT, CARLSBAD, CALIFORNIA, 92010
Covered Properties (10)
Modulation of Apolipoprotein C-Iii Expression
Patent: 7,598,227 →
Application: 10/418,780 →
Publication: US 2004/0208856
Methods of Obtaining Active Antisense Compounds
Patent: 7,592,440 →
Application: 10/686,317 →
Publication: US 2004/0115716
Polycyclic Sugar Surrogate-Containing Oligomeric Compounds and Compositions for Use in Gene Modulation
Patent: 7,696,345 →
Application: 10/701,285 →
Publication: US 2004/0171570
Modulation of the Rna Interference Pathway
Patent: 7,709,453 →
Application: 10/852,630 →
Publication: US 2005/0037387
Trpm-2 Antisense Therapy
Patent: 7,592,323 →
Application: 11/276,581 →
Antisense Modulation of Superoxide Dismutase 1, Soluble Expression
Patent: 7,678,895 →
Application: 11/449,207 →
Publication: US 2006/0293269
Methods for Slowing Familial Als Disease Progression
Patent: 7,622,455 →
Application: 11/526,134 →
Publication: US 2007/0117772
Supports for Oligomer Synthesis
Patent: 7,576,119 →
Application: 11/622,325 →
Publication: US 2008/0021224
Polymeric Beads for Oligomer Synthesis
Patent: 7,700,706 →
Application: 11/958,148 →
Publication: US 2008/0097028
Bis-Modified Bicyclic Nucleic Acid Analogs
Patent: 7,666,854 →
Application: 12/331,226 →
Publication: US 2009/0156792
Related Assignments (1)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Mar 11, 2021
From: IONIS PHARMACEUTICALS, INC.
To: BIOGEN MA INC.
Reel/Frame 055608/0382 →